Cargando…

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting

BACKGROUND: Long-term efficacy of liraglutide, a glucagon-like peptide-1 analog, on body weight and glycemic control has not been studied in Indian Type 2 diabetes mellitus (T2DM) subjects. AIM: To evaluate the effect of liraglutide on glycemic control and body weight for 1 year in Indian T2DM patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaur, Parjeet, Mahendru, Shama, Mithal, Ambrish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040036/ https://www.ncbi.nlm.nih.gov/pubmed/27730066 http://dx.doi.org/10.4103/2230-8210.183825

Ejemplares similares

Adverse Effect Profile and Effectiveness of Sodium Glucose Co-transporter 2 Inhibitors (SGLT2i) - A Prospective Real-world Setting Study
por: Gill, Harmandeep Kaur, et al.
Publicado: (2019)

Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India
por: Kaur, Parjeet, et al.
Publicado: (2014)

Usage of pioglitazone at Medanta, the Medicity
por: Mithal, Ambrish, et al.
Publicado: (2014)

Vitamin D and insulin resistance in postmenopausal Indian women
por: Agarwal, Niti, et al.
Publicado: (2014)

Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Effect of two different doses of oral cholecalciferol supplementation on serum 25-hydroxy-vitamin D levels in healthy Indian postmenopausal women: A randomized controlled trial
por: Agarwal, Niti, et al.
Publicado: (2013)

Video Consultation Versus In-Person Clinic Visit for Glycemic Control in Type 2 Diabetes during COVID-19 Pandemic (VIP-CD Study)
por: Dutta, Aditya, et al.
Publicado: (2021)

Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19
por: Jevalikar, Ganesh, et al.
Publicado: (2021)

Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting
por: Kesavadev, Jothydev, et al.
Publicado: (2012)

Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2021)

Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting
por: Simioni, N., et al.
Publicado: (2018)

Once Weekly Dulaglutide Therapy in Type 2 Diabetic Subjects, Real-world Evidence from a Tertiary Care Diabetes Center in India
por: Wasir, Jasjeet S., et al.
Publicado: (2018)

Impact of preoperative imaging on surgical approach for primary hyperparathyroidism: Data from single institution in India
por: Kaur, Parjeet, et al.
Publicado: (2016)

High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes
por: Mithal, Ambrish, et al.
Publicado: (2021)

Clinical experience with exenatide in obese North Indian patients with type 2 diabetes mellitus
por: Bawa, Tarunika, et al.
Publicado: (2013)

Low FT3 is an independent marker of disease severity in patients hospitalized for COVID-19
por: Dutta, Aditya, et al.
Publicado: (2021)

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
por: Ostawal, Amrita, et al.
Publicado: (2016)

Efficacy and safety of liraglutide in Indian adolescents with obesity
por: Kochar, I. S., et al.
Publicado: (2019)

Is there an association between liraglutide use and female breast cancer in a real-world setting?
por: Funch, Donnie, et al.
Publicado: (2018)

Liraglutide – Indian Experience
por: Anirban, Majumder, et al.
Publicado: (2018)

Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study
por: Ghosal, S., et al.
Publicado: (2018)

Prevalence of dyslipidemia in adult Indian diabetic patients: A cross sectional study (SOLID)
por: Mithal, Ambrish, et al.
Publicado: (2014)

Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study
por: Mezquita-Raya, Pedro, et al.
Publicado: (2015)

Efficacy of Liraglutide in a Real-Life Cohort
por: Heymann, Anthony, et al.
Publicado: (2014)

Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study
por: Lapolla, Annunziata, et al.
Publicado: (2017)

Liraglutide Effectiveness in Type 2 Diabetes: Insights from a Real-World Cohort of Portuguese Patients
por: Silva-Nunes, José, et al.
Publicado: (2022)

Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting
por: Ko, Hae-Jin, et al.
Publicado: (2022)

Indian Phenotype Characteristics Among Patients with Type 2 Diabetes Mellitus: Insights from a Non-interventional Nationwide Registry in India
por: Kalra, Sanjay, et al.
Publicado: (2022)

Long-Term Effectiveness of Liraglutide in Association with Patients’ Baseline Characteristics in Real-Life Setting in Croatia: An Observational, Retrospective, Multicenter Study
por: Berkovic, Maja Cigrovski, et al.
Publicado: (2017)

Erratum to: Efficacy of Liraglutide in a Real-Life Cohort
por: Heymann, Anthony, et al.
Publicado: (2014)

Evaluating the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real‐world clinical evidence
por: Raya, Pedro Mezquita, et al.
Publicado: (2019)

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2019)

Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
por: Tanaka, Kenichi, et al.
Publicado: (2022)

Effect of vitamin D supplementation on bone health parameters of healthy young Indian women
por: Malhotra, Nidhi, et al.
Publicado: (2009)

Pilot case-control investigation of risk factors for hip fractures in the urban Indian population
por: Jha, Ruchira M, et al.
Publicado: (2010)

Gestational diabetes in India: Science and society
por: Mithal, Ambrish, et al.
Publicado: (2015)

Clinical effectiveness of liraglutide vs basal insulin in a real‐world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes
por: Overbeek, Jetty A., et al.
Publicado: (2018)

Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
por: Li, Qian, et al.
Publicado: (2014)

Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone
por: Sullivan, Sean D, et al.
Publicado: (2009)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Neumiller, Joshua J, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kh5c3nbpeml6s9v2lj2jl6ep2u